Tirzepatide
Tirzepatide is a synthetic 39-residue peptide engineered to co-activate the GIP and GLP-1 receptors, with C20 fatty-diacid acylation for an extended pharmacokinetic profile. It is a reference compound in dual-incretin signaling research.
A benchmark dual-incretin reference compound for receptor-signaling studies.
What it is
Tirzepatide is a 39-amino-acid chimeric peptide that activates both the GIP and GLP-1 receptors. A C20 fatty-diacid moiety supports albumin binding and an extended half-life.
It is used as a reference compound in pre-clinical dual-incretin signaling research, benchmarking single- versus dual-receptor activity. For laboratory use only.
Reconstitution & storage
- Reconstitute with bacteriostatic water — add slowly down the vial wall and swirl gently; do not shake.
- Store lyophilized vials at -20°C; once reconstituted keep at 2–8°C and use within ~4 weeks.
- Protect from light and avoid repeated freeze–thaw cycles.
Cited research applications
Questions
Related compounds
For Research Use Only. Not for human or animal consumption. This product has not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease. Tirzepatide is sold strictly as a research chemical for in-vitro and pre-clinical laboratory investigation only.